- Current languageen
Pharmaceuticals - Community Register
Community register of medicinal products for human use
|Invented name:||Pioglitazone Teva This product is authorized under a different brandname in the EU in the folowing languages: - Pioglitazon Teva (DE) - Pioglitazona Teva (ES) - Pioglitazon Teva (NL) - Pioglitazona Teva (PT) - Pioglitazon Teva (SL)|
|Auth. number :||EU/1/12/757|
|ATC:||Anatomical main group: A - Alimentary tract and metabolism|
Therapeutic subgroup: A10 - Drugs used in diabetes
Pharmacological subgroup: A10B - Blood glucose lowering drugs, excluding insulins
Chemical subgroup: A10BG - Thiazolidinediones
Chemical substance: A10BG03 - Pioglitazone
(See WHO ATC Index)
|Marketing Authorisation Holder:||Teva Pharma B.V.
Computerweg 10, NL-3542 DR Utrecht, Nederland
The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".|
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register.
|Close date procedure||Procedure type||EMEA number||Decision||summary publ||decision docs||annex|
|28/03/2012||Centralised - Authorisation - Decision addressed to Member States||EMEA/H/C/2297||(2012)2181 of 26/03/2012|
|29/03/2012||Centralised - Authorisation||EMEA/H/C/2297||(2012)2182 of 26/03/2012|